Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional study

被引:9
作者
Chedid, Marcio F. [1 ,2 ]
do Nascimento, Filipe V. [3 ]
de Oliveira, Fernanda S. [3 ]
de Souza, Bianca M. [1 ]
Kruel, Cleber R. P. [1 ,2 ]
Gurski, Richard R. [1 ,2 ]
Canani, Luis H. [3 ,4 ]
Crispim, Daisy [3 ,4 ]
Gerchman, Fernando [3 ,4 ]
机构
[1] Univ Fed Rio Grande do Sul, Postgrad Program Surg Sci, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Gastrointestinal Surg, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrinol & Metab, Rua Ramiro Barcelos 2350,Predio 12,4 Andar, BR-90035003 Porto Alegre, RS, Brazil
关键词
Gene expression; Cortisol; 11-beta hydroxysteroid dehydrogenase type 1; Hexose-6-phosphate dehydrogenase; Visceral; Adipose tissue; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CORTISONE REDUCTASE DEFICIENCY; HEPATIC INSULIN SENSITIVITY; HEXOSE-6-PHOSPHATE DEHYDROGENASE; METABOLIC SYNDROME; GENE POLYMORPHISMS; SELECTIVE-INHIBITION; ADIPOSE-TISSUE; EXPRESSION; ASSOCIATION;
D O I
10.1186/s13098-019-0474-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The enzyme 11-beta hydroxysteroid dehydrogenase type 1 (HSD11B1) converts inactive cortisone to active cortisol in a process mediated by the enzyme hexose-6-phosphate dehydrogenase (H6PD). The generation of cortisol from this reaction may increase intra-abdominal cortisol levels and contribute to the physiopathogenesis of obesity and metabolic syndrome (MetS). The relationship of HSD11B1 rs45487298 and H6PD rs6688832 polymorphisms with obesity and MetS was studied. We also studied how HSD11B1 abdominal subcutaneous (SAT) and visceral adipose tissue (VAT) gene expression is related to body fat distribution. Methods Rates of obesity and MetS features were cross-sectionally analyzed according to these polymorphisms in 1006 Brazilian white patients with type 2 diabetes (T2DM). Additionally, HSD11B1 expression was analyzed in VAT and SAT in a different cohort of 28 participants with and without obesity who underwent elective abdominal operations. Results Although polymorphisms of the two genes were not individually associated with MetS features, a synergistic effect was observed between both. Carriers of at least three minor alleles exhibited lower BMI compared to those with two or fewer minor alleles adjusting for gender and age (27.4 +/- 4.9 vs. 29.3 +/- 5.3 kg/m(2); P = 0.005; mean +/- SD). Obesity frequency was also lower in the first group (24.4% vs. 41.6%, OR = 0.43, 95% CI 0.21-0.87; P = 0.019). In the second cohort of 28 subjects, HSD11B1 gene expression in VAT was inversely correlated with BMI (r = - 0.435, P = 0.034), waist circumference (r = - 0.584, P = 0.003) and waist-to-height ratio (r = - 0.526, P = 0.010). Conclusions These polymorphisms might interact in the protection against obesity in T2DM individuals. Obese individuals may have decreased intra-abdominal VAT HSD11B1 gene expression resulting in decreasing intra-abdominal cortisol levels as a compensatory mechanism against central and general adiposity.
引用
收藏
页数:10
相关论文
共 45 条
  • [1] Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains
    Alberts, P
    Nilsson, C
    Selén, G
    Engblom, LOM
    Edling, NHM
    Norling, S
    Klingström, G
    Larsson, C
    Forsgren, M
    Ashkzari, M
    Nilsson, CE
    Fiedler, M
    Bergqvist, E
    Öhman, B
    Björkstrand, E
    Abrahmsén, LB
    [J]. ENDOCRINOLOGY, 2003, 144 (11) : 4755 - 4762
  • [2] Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance
    Andrews, RC
    Herlihy, O
    Livingstone, DEW
    Andrew, R
    Walker, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) : 5587 - 5593
  • [3] Effects of the 11β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
    Andrews, RC
    Rooyackers, O
    Walker, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) : 285 - 291
  • [4] Accuracy of insulin resistance indices for metabolic syndrome: a cross-sectional study in adults
    Antoniolli, Luciana Pavan
    Nedel, Barbara Limberger
    Pazinato, Tassia Cividanes
    Mesquita, Leonardo de Andrade
    Gerchman, Fernando
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [5] Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum
    Bánhegyi, G
    Benedetti, A
    Fulceri, R
    Senesi, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) : 27017 - 27021
  • [6] The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes
    Canani, LH
    Capp, C
    Ng, DPK
    Choo, SGL
    Maia, AL
    Nabinger, GB
    Santos, K
    Crispim, D
    Roisemberg, I
    Krolewski, AS
    Gross, JL
    [J]. DIABETES, 2005, 54 (11) : 3326 - 3330
  • [7] Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population
    Devang, Nayana
    Satyamoorthy, Kapaettu
    Rai, Padmalatha S.
    Nandini, M.
    Rao, Satish
    Phani, Nagaraja M.
    Adhikari, Prabha
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 131 : 142 - 148
  • [8] Association of HSD11B1 polymorphic variants and adipose tissue gene expression with metabolic syndrome, obesity and type 2 diabetes mellitus: a systematic review
    do Nascimento, Filipe Valvassori
    Piccoli, Vanessa
    Beer, Mayara Abichequer
    von Frankenberg, Anize Delfino
    Crispim, Daisy
    Gerchman, Fernando
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [9] Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
    Draper, N
    Walker, EA
    Bujalska, IJ
    Tomlinson, JW
    Chalder, SM
    Arlt, W
    Lavery, GG
    Bedendo, O
    Ray, DW
    Laing, I
    Malunowicz, E
    White, PC
    Hewison, M
    Mason, PJ
    Connell, JM
    Shackleton, CHL
    Stewart, PM
    [J]. NATURE GENETICS, 2003, 34 (04) : 434 - 439
  • [10] Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome
    Draper, Nicole
    Powell, Brenda L.
    Franks, Steve
    Conway, Gerard S.
    Stewart, Paul M.
    McCarthy, Mark I.
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (01) : 64 - 70